213 related articles for article (PubMed ID: 3115833)
1. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
Friedman AJ; Barbieri RL; Doubilet PM; Fine C; Schiff I
Fertil Steril; 1988 Mar; 49(3):404-9. PubMed ID: 2963759
[TBL] [Abstract][Full Text] [Related]
3. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS
Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
Friedman AJ; Harrison-Atlas D; Barbieri RL; Benacerraf B; Gleason R; Schiff I
Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
7. Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo.
Friedman AJ; Rein MS; Pandian MR; Barbieri RL
Fertil Steril; 1990 Feb; 53(2):250-3. PubMed ID: 2105242
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
9. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Ando M; Suzuki M
Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.
Friedman AJ; Rein MS; Harrison-Atlas D; Garfield JM; Doubilet PM
Fertil Steril; 1989 Nov; 52(5):728-33. PubMed ID: 2509250
[TBL] [Abstract][Full Text] [Related]
11. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
[TBL] [Abstract][Full Text] [Related]
13. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
Friedman AJ
Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
Stovall TG; Ling FW; Henry LC; Woodruff MR
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Friedman AJ; Lobel SM; Rein MS; Barbieri RL
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
[TBL] [Abstract][Full Text] [Related]
16. Histopathological changes in leiomyomata treated with leuprolide acetate.
Upadhyaya NB; Doody MC; Googe PB
Fertil Steril; 1990 Nov; 54(5):811-4. PubMed ID: 2121550
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H
Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
[TBL] [Abstract][Full Text] [Related]
18. Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging.
Williams IA; Shaw RW
Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):111-7. PubMed ID: 2137421
[TBL] [Abstract][Full Text] [Related]
19. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix.
Flierman PA; Oberyé JJ; van der Hulst VP; de Blok S
BJOG; 2005 May; 112(5):638-42. PubMed ID: 15842290
[TBL] [Abstract][Full Text] [Related]
20. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri.
Coddington CC; Collins RL; Shawker TH; Anderson R; Loriaux DL; Winkel CA
Fertil Steril; 1986 May; 45(5):624-9. PubMed ID: 3084300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
